Opinion|Articles|December 15, 2023
Supplements and Featured Publications
- Treatment of Spinal Muscular Atrophy: Managed Care Considerations for Gene Therapy
Treatment of Spinal Muscular Atrophy: Managed Care Considerations for Gene Therapy
Advertisement
This AJMC® Clinical Brief focuses on managed care considerations for the treatment of spinal muscular atrophy.
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
Tirzepatide Plus Hormone Therapy Boosts Weight Loss in Menopause: Regina Castaneda, MD
2
Digital, Blood-Based Innovations Transform Alzheimer Disease Detection: Ken Cohen, MD, FACP
3
Elinzanetant Shows Consistent Efficacy, Safety, and Sleep Benefits Across Studies
4
FDA Approves Elinzanetant, a Hormone-Free Option for Hot Flashes in Menopause
5











































